Irofulven cas 920014-72-8
3 Inquiries
920014-72-8
Pharmaceutical Grade
99.56%
qingdao
Million
1g 10g 100g 1kg/bag 25kg/Cardboard Drum
2065-06-24
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Setmelanotide
Other Name:Setmelanotide;920014-72-8;UNII-N7T15V1FUY;BIM-22493;RM-493;Imcivree;N7T15V1FUY;(4R,7S,10S,13R,16S,19R,22R)-22-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-13-benzyl-10-[3-(diaminomethylideneamino)propyl]-16-(1H-imidazol-5-ylmethyl)-7-(1H-indol-3-ylmethyl)-19-methyl-6,9,12,15,18,21-hexaoxo-1,2-dithia-5,8,11,14,17,20-hexazacyclotricosane-4-carboxamide;Setmelanotide [USAN:INN];GTPL9272
CAS No.:920014-72-8
Molecular Formula:C49H68N18O9S2
InChIKeys:HDHDTKMUACZDAA-PHNIDTBTSA-N
Molecular Weight:1117.31
Exact Mass:1116.49
UNII:N7T15V1FUY
ATC Code:A08AA
Categories:
Characteristics-
PSA:
494.76
XLogP3:3.0807
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Avanafil,Tirzepatide,Semaglutide,Pregabalin,Nootropics,MT2
-
Location:
Room 1-2208, Lianhecaifu Square, No2177, Tianchen Road, Gaoxin District, Jinan City, Shandong Province, China
-
Payment Terms:
L/C,100% TT in advance
-
Average lead Time:
3
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2012
-
Certifications:
business license
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted
United Kingdom
Setmelanotide
1 G Dec 17, 2024
United Kingdom
Setmelanotide
1 G Dec 17, 2024
United States
Setmelanotide
2 G May 20, 2024 Post an enquiry for this product
